Coming soon: 2023 Open Enrollment

The Open Enrollment (OE) period for 2023 is coming up, Nov. 1–30. This is the one time each year when you can make certain changes to your benefits, effective Jan. 1, 2023.

The Open Enrollment benefit change will arrive in your Workday inbox on Nov. 1. It is recommended all benefit-eligible employees open this event to:

  • Review current elections,
  • Make any desired changes if applicable,
  • Address the spousal surcharge attestation if required, or
  • Confirm you wish to maintain the same coverage for 2023.

If you do not review and submit your elections by the Nov. 30 deadline, you will remain in your current medical/dental plans and dependent coverage if applicable. If you are currently enrolled in FSA or DCAP and wish to continue this benefit in 2023, you will need to re‑enroll.

Percipio is your one‑stop source for Open Enrollment info. There, you can find links for many relevant sources, instructions on how to make changes, informational videos, and more. You can also view a schedule of available presentations and register to attend.

Contact HRS with questions.

The Notices and Announcements section is provided as a service to the WSU community for sharing events such as lectures, trainings, and other highly transactional types of information related to the university experience. Information provided and opinions expressed may not reflect the understanding or opinion of WSU. Accuracy of the information presented is the responsibility of those who submitted it. The self-uploaded posts are reviewed for compliance with state statutes and ethics guidelines but are not edited for spelling, grammar, or clarity.

Next Story

Recent News

THC lingers in breastmilk with no clear peak point

WSU-led research found that, unlike alcohol, when THC was detected in breastmilk there was no consistent time when its concentration peaked and started to decline.

WSU fungus researcher Katy Ayers lands Fulbright to UK

Ayers received the Fulbright U.S. Student Award to study potential antifungal drug targets at the University of Exeter in southwest England.